CN102552995A - Personal lubricant - Google Patents
Personal lubricant Download PDFInfo
- Publication number
- CN102552995A CN102552995A CN2010105919550A CN201010591955A CN102552995A CN 102552995 A CN102552995 A CN 102552995A CN 2010105919550 A CN2010105919550 A CN 2010105919550A CN 201010591955 A CN201010591955 A CN 201010591955A CN 102552995 A CN102552995 A CN 102552995A
- Authority
- CN
- China
- Prior art keywords
- human body
- body lubricants
- active compound
- extract
- vasodilator active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000314 lubricant Substances 0.000 title claims abstract description 40
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 229940124549 vasodilator Drugs 0.000 claims abstract description 18
- 239000003071 vasodilator agent Substances 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 229910052708 sodium Inorganic materials 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- 102000014150 Interferons Human genes 0.000 claims description 4
- 108010050904 Interferons Proteins 0.000 claims description 4
- 229940079322 interferon Drugs 0.000 claims description 4
- 229910002651 NO3 Inorganic materials 0.000 claims description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 3
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 claims description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 3
- 102000004305 alpha Adrenergic Receptors Human genes 0.000 claims description 3
- 108090000861 alpha Adrenergic Receptors Proteins 0.000 claims description 3
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 3
- 239000002571 phosphodiesterase inhibitor Substances 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 150000003180 prostaglandins Chemical class 0.000 claims description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 3
- 239000003087 receptor blocking agent Substances 0.000 claims description 3
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 claims description 2
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- CHZVHNZRFPALHO-UHFFFAOYSA-N [Br].[Na] Chemical compound [Br].[Na] CHZVHNZRFPALHO-UHFFFAOYSA-N 0.000 claims description 2
- 239000009188 angelicae sinensis extract Substances 0.000 claims description 2
- 230000002500 effect on skin Effects 0.000 claims description 2
- 229930014456 matrine Natural products 0.000 claims description 2
- 239000002089 prostaglandin antagonist Substances 0.000 claims description 2
- 210000001215 vagina Anatomy 0.000 abstract description 11
- 210000003899 penis Anatomy 0.000 abstract description 8
- 230000001568 sexual effect Effects 0.000 abstract description 6
- 210000004877 mucosa Anatomy 0.000 abstract description 5
- 210000003029 clitoris Anatomy 0.000 abstract description 4
- 241001313288 Labia Species 0.000 abstract description 3
- 210000003756 cervix mucus Anatomy 0.000 abstract description 3
- 230000008439 repair process Effects 0.000 abstract description 3
- 206010036596 premature ejaculation Diseases 0.000 abstract description 2
- 238000005461 lubrication Methods 0.000 abstract 1
- 206010046901 vaginal discharge Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229960000711 alprostadil Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 2
- 229910001948 sodium oxide Inorganic materials 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a personal lubricant which comprises a vasodilator active compound. The personal lubricant applies the vasodilator active compound to the lubrication in terms of sexual life, not only can help a penis to sufficiently erect and prevent premature ejaculation, but also ensures that a vagina/labia is engorged and a clitoris is sufficiently erected, and promotes the vaginal discharge to be increased, can also protect and moisten the vagina and repair the vaginal mucosa, and achieves multiple purposes.
Description
Technical field
The present invention relates to human body lubricants, a kind of human body lubricants that can increase voluptus and help the erection effect specifically is provided.
Background technology
Existing human body lubricants has oily lubricant and water-based lubricant two big classes, and it does not increase female sexual pleasure and helps the erection effect.
And in actual life, along with involutional arrival, each organ of human body can be old and feeble gradually.Aspect sexual life, the male often shows as penis can not normal erection or erect not hardly, and the women then shows as diseases such as vaginal dryness, libido be low.The particularly increase of the deterioration of local environment and stress, above symptom are very general and the impetus of growth year by year arranged in the adult.
Therefore, a kind of human body lubricants that can effectively improve adult's life quality being provided is market institute urgent needs.
Summary of the invention
The objective of the invention is in order to overcome the deficiency of above-mentioned human body lubricants, a kind of human body lubricants that can increase women's pleasant sensation and male penis erection effectively is provided.
The present invention realizes through following technical scheme:
A kind of human body lubricants, it includes vasodilator active compound.
Described human body lubricants includes vasodilator active compound and matter acid sodium.
Said vasodilator active compound comprises nitrate, peptide, antihypertensive, long-acting and fugitive α-adrenergic receptor blocker, prostaglandin and phosphodiesterase inhibitor.
Described human body lubricants also includes Herba Epimedii extract, Radix Puerariae extract puerarin, Herba Trifolii Pratentis extract, Radix Angelicae Sinensis extract, beans extract, interferon, benzene and pricks in bromine sodium, Galla Chinensis extract, the matrine one or more.
Described human body lubricants also contains interferon.
Described human body lubricants also includes dermal osmosis accelerator.
Human body lubricants is buffered to PH3.5-5.
Contain the application of vasodilator active compound in human body lubricants and condom lubricant.
Contain the application in human body lubricants and condom lubricant of vasodilator active compound and hyaluronate sodium.
Vasodilator active compound among the present invention; Can effective stimulus with increase the blood flow in cavernous body of penis, vagina, labia, the cavernous body of clitoris and promote its hyperemia; Thereby penis, clitoris are fully erected, and alleviating masculinity and femininity can't sexual intercourse or be difficult to reach orgastic symptom.Simultaneously, the vasodilator active compound among the present invention can also effectively promote the increase of vaginal secretions, for sexual intercourse good channel environment is provided smoothly.
As for the above-mentioned effect and the mechanism of action of vasodilator active compound, confirmed by the modern medicine Institute of Science already, no longer repeat to discuss here.
Need to prove that especially the matter acid sodium among the present invention, has special physiological properties at natural being present in the tissue:
1, intelligent moisture-keeping function: matter acid sodium is described as nature moisturizing factor, and the carboxyl in its molecule can form hydrogen bond and combine a large amount of water with other polar groups with water.Can also regulate water absorption automatically according to the humidity of environment, make vagina remain optimum humidity, this is that common wetting agent is incomparable.
2, improve the vagina skin quality: matter acid sodium is coated with into the skin of vulva mucous membrane surface, can form one deck viscous transparent hydration shell, effectively stops water loss, and part matter acid sodium can also be penetrated into skin corium, regulates water absorption, can make vagina remain optimum humidity.
3, adhesion-promoting effect: matter acid sodium is the macromolecule mucopolysaccharide, also can show good adhesion-promoting effect even content is low, the efficient effect that above-mentioned vasodilator active compound performance is used.
4, bio-adhesive effect: matter acid sodium can stick with vaginal mucosa, and the protection vaginal mucosa is injury-free.
5, reparation and promoting healing effect: matter acid sodium is that wound does not have the indispensable material of cicatrix reparation, can effectively suppress colpitis here, repairs vaginal mucosa.
6, slow releasing function: matter acid sodium molecule is just as a dynamic molecular sieve, and medicine can be embedded in the cancellated macromole of matter acid sodium through covalent, is attached to vagina surface for a long time together with medicine, promotes the utilization and the absorption of medicine.
Therefore; Matter acid sodium and vasodilator active compound are applied to the lubricated of sexual life aspect; Not only can help penis fully to erect, prevent premature ejaculation; Can make again that vagina/labia is congested, clitoris fully erects and promotes vaginal secretions to increase, more can protect vagina, moisten vagina and repair vaginal mucosa, in fact good recipe for achieving many things at one stroke.
Have medicines such as the plant extract of androgen-like action, plant extract, antibacterial-anti-inflammatory drug and in above-mentioned prescription, add again, then can further enrich the function of human body lubricants of the present invention with estrogen-like effects.
Multifunctional human lubricant of the present invention during use, is coated on it on penis, vaginal orifice or the condom, directly brings medicine into intravaginal by penis/condom vagina is carried out maintenance and treatment.
The specific embodiment
Below in conjunction with specific embodiment the present invention is described further:
Embodiment 1:
In 100 milliliters of human body lubricants, PGE1 0.1 gram, glycerol 15 grams, hyaluronate sodium 0.5 gram, purified water surplus.
Embodiment 2:
In 100 milliliters of human body lubricants, PGE1 0.5 gram, hyaluronate sodium 0.15 gram, sodium oxide 0.5 gram, Borax 0.05 gram, ethyl hydroxybenzoate 0.03 gram, purified water surplus.
Embodiment 3:
In 100 milliliters of human body lubricants, PGE1 0.15 gram, hyaluronate sodium 0.5 gram, Herba Epimedii extract 0.05 gram, Radix Puerariae extract puerarin 0.1 gram, Galla Chinensis extract 0.05 gram, sodium oxide 0.5 gram, Borax 0.05 gram, ethyl hydroxybenzoate 0.03 gram, purified water surplus.
Claims (10)
1. human body lubricants, it contains vasodilator active compound.
2. human body lubricants according to claim 1, it contains vasodilator active compound and matter acid sodium.
3. human body lubricants according to claim 1 and 2; It is characterized in that said vasodilator active compound comprises nitrate, peptide, antihypertensive, long-acting and fugitive α-adrenergic receptor blocker, prostaglandin and phosphodiesterase inhibitor.
4. human body lubricants according to claim 1 and 2; It is characterized in that, also include Herba Epimedii extract, Radix Puerariae extract puerarin, Herba Trifolii Pratentis extract, Radix Angelicae Sinensis extract, beans extract, interferon, benzene and prick in bromine sodium, Galla Chinensis extract, the matrine one or more.
5. human body lubricants according to claim 1 and 2 is characterized in that, also contains interferon.
6. human body lubricants according to claim 1 and 2 is characterized in that, also contains dermal osmosis accelerator.
7. human body lubricants according to claim 1 and 2 is characterized in that, human body lubricants is buffered to PH3.5-5.
8. contain the application of vasodilator active compound in human body lubricants and condom lubricant.
9. contain the application in human body lubricants and condom lubricant of vasodilator active compound and hyaluronate sodium.
10. one kind like claim 8 or 9 described human body lubricants; It is characterized in that said vasodilator active compound is one or more in nitrate, peptide, antihypertensive, long-acting and fugitive α-adrenergic receptor blocker, prostaglandin, the phosphodiesterase inhibitor.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105919550A CN102552995A (en) | 2010-12-07 | 2010-12-07 | Personal lubricant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105919550A CN102552995A (en) | 2010-12-07 | 2010-12-07 | Personal lubricant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102552995A true CN102552995A (en) | 2012-07-11 |
Family
ID=46400440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105919550A Pending CN102552995A (en) | 2010-12-07 | 2010-12-07 | Personal lubricant |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552995A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405594A (en) * | 2013-05-30 | 2013-11-27 | 石杰克 | Water-soluble personal lubricant, preparation method thereof, and condom employing lubricant |
| CN109700897A (en) * | 2019-02-14 | 2019-05-03 | 重庆市洲仨科技发展有限公司 | A kind of female health external application Essence |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000060939A1 (en) * | 1999-04-13 | 2000-10-19 | John Lezdey | Lubrication composition |
| CN1498096A (en) * | 2001-03-30 | 2004-05-19 | ��ͼ��ҽҩ��չ����˾ | Condoms containing compositions that induce an erection |
| CN1655740A (en) * | 2002-04-16 | 2005-08-17 | 富图拉医药发展有限公司 | condom |
| WO2006127057A1 (en) * | 2005-05-24 | 2006-11-30 | Lyle Corporate Drvelopment, Inc. | Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction |
| CN101422461A (en) * | 2007-12-11 | 2009-05-06 | 北京琥珀光华医药科技开发有限公司 | Preparation method of matrine vagina effervescence tablet and use thereof |
| CN101720223A (en) * | 2007-07-03 | 2010-06-02 | 因德纳有限公司 | Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions |
| CN101773513A (en) * | 2009-01-14 | 2010-07-14 | 邢建慧 | Water soluble body lubricant with natural antibacterial components and with pH value consistence with pH value of vagina |
-
2010
- 2010-12-07 CN CN2010105919550A patent/CN102552995A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000060939A1 (en) * | 1999-04-13 | 2000-10-19 | John Lezdey | Lubrication composition |
| CN1498096A (en) * | 2001-03-30 | 2004-05-19 | ��ͼ��ҽҩ��չ����˾ | Condoms containing compositions that induce an erection |
| CN1655740A (en) * | 2002-04-16 | 2005-08-17 | 富图拉医药发展有限公司 | condom |
| WO2006127057A1 (en) * | 2005-05-24 | 2006-11-30 | Lyle Corporate Drvelopment, Inc. | Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction |
| CN101720223A (en) * | 2007-07-03 | 2010-06-02 | 因德纳有限公司 | Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions |
| CN101422461A (en) * | 2007-12-11 | 2009-05-06 | 北京琥珀光华医药科技开发有限公司 | Preparation method of matrine vagina effervescence tablet and use thereof |
| CN101773513A (en) * | 2009-01-14 | 2010-07-14 | 邢建慧 | Water soluble body lubricant with natural antibacterial components and with pH value consistence with pH value of vagina |
Non-Patent Citations (1)
| Title |
|---|
| HARIN PADMA-NATHAN ETAL.: ""Efficacy and Safety of Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD): A Double-Blind, Multicenter, Randomized, and Placebo-Controlled Clinical Trial"", 《JOURNAL OF SEX & MARITAL THERAPY 》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405594A (en) * | 2013-05-30 | 2013-11-27 | 石杰克 | Water-soluble personal lubricant, preparation method thereof, and condom employing lubricant |
| CN109700897A (en) * | 2019-02-14 | 2019-05-03 | 重庆市洲仨科技发展有限公司 | A kind of female health external application Essence |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20044699L (en) | Vaginal Care Composition | |
| HRP20161574T1 (en) | Novel Topical Drugs Based on Sulfated Hyaluronic Acid as a Activator or Inhibition of Cytokine Activity | |
| US5888523A (en) | Topical non-steroidal anti-inflammatory drug composition | |
| CN110604810A (en) | Hydrolyzed collagen gel for gynecology and preparation method thereof | |
| CN102716511A (en) | Antibacterial and hypoallergenic spray | |
| CL2008002466A1 (en) | Anhydrous topical pharmaceutical composition comprising a vasodilator and an acceptable carrier; use of topical anhydrous composition on genital areas for improved sexual well-being. | |
| CN102552995A (en) | Personal lubricant | |
| CN101450033B (en) | Cosmetic of senility resistant composition and preparation method thereof | |
| RU2372933C1 (en) | Medical product and medicinal composition for manufacturing thereof | |
| JP2013527193A (en) | Kit of parts for treating and / or preventing skin ulcers | |
| WO2005112872A1 (en) | Peroxide compounds for the prevention and treatment of sexual dysfunction in humans | |
| CN102028647A (en) | Composition for relieving legs and preparation method thereof | |
| CN113616774A (en) | Plant stem cell-containing antibacterial composition, maintenance antibacterial liquid and preparation method thereof | |
| CN101112417B (en) | Rheum defervescence liniment and method for preparing the same | |
| CN111631991A (en) | Private nursing lotion | |
| CN2507408Y (en) | Minimally invasive radical treatment of underarm odor surgical separator | |
| CN115381925A (en) | A kind of cervical repair dressing and preparation method thereof | |
| US7563464B1 (en) | Treatment of mucosal membranes utilizing phytoestrogen | |
| CN1151878A (en) | Prepn of Chinese medicine for gynopathy | |
| TR202009156A2 (en) | Herbal supplement cream that supports wound healing and inflammation reduction | |
| CN120053517B (en) | Externally-applied erection aid for men and preparation method and application thereof | |
| CN103877452A (en) | Vaginal washing liquid made of chitosan and preparation method thereof | |
| KR101691494B1 (en) | Composition for promoting the volume of skin | |
| RU2262948C1 (en) | Method for treating candidosis vulvovaginitis in pregnant women | |
| CN103767900A (en) | Herbal feminine nursing washing lotion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120711 |